Publication | Open Access

E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma

Xenograft Mouse ModelTumor Drug ConcentrationMedicineMetronomic TherapyPathologyHead And Neck CancerAdenovirus-carrying Endostatin GeneMetronomic ChemotherapyCancer TreatmentNeck OncologyOncologyCell BiologyCancer ResearchTumor Biology